High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy

AIDS. 2021 Nov 15;35(14):2409-2410. doi: 10.1097/QAD.0000000000003043.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents* / adverse effects
  • Child
  • Female
  • HIV Infections* / drug therapy
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control
  • Milk, Human
  • Nevirapine / adverse effects

Substances

  • Anti-HIV Agents
  • Nevirapine

Associated data

  • ClinicalTrials.gov/NCT01127204